Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28

K. A. Papp*, K. Reich, A. Blauvelt, A. B. Kimball, M. Gooderham, S. K. Tyring, R. Sinclair, D. Thaci, Q. Li, N. Cichanowitz, S. Green, C. La Rosa

*Corresponding author for this work
6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28'. Together they form a unique fingerprint.

Medicine & Life Sciences